NCT06059508View on ClinicalTrials.gov

Phase I Clinical Study of SHR-5495 in the Treatment of Patients With Advanced Malignant Tumors

PHASE1RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

October 25, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Advanced Malignant Tumor
Interventions
DRUG

SHR-5495 for injection

SHR-5495 for injection

Trial Locations (1)

250117

RECRUITING

Shandong First Medical University Affiliated Cancer Hospital, Jinan

All Listed Sponsors
lead

Suzhou Suncadia Biopharmaceuticals Co., Ltd.

INDUSTRY